Exploratory biomarker analysis from neoadjuvant atezolizumab, pertuzumab, trastuzumab plus docetaxel (NEO-PATH) in HER2+early breast cancer

  • Ahn, H. K.
  • Park, K.
  • Sim, S. H.
  • Suh, K. J.
  • Kim, M. H.
  • 외 5명
Citations

WEB OF SCIENCE

0
제목
Exploratory biomarker analysis from neoadjuvant atezolizumab, pertuzumab, trastuzumab plus docetaxel (NEO-PATH) in HER2+early breast cancer
저자
Ahn, H. K.Park, K.Sim, S. H.Suh, K. J.Kim, M. H.Park, W-Y.Choi, Y-L.Im, S-A.Jung, K. H.Park, Y. H.
DOI
10.1016/j.annonc.2022.03.020
발행일
2022-05
유형
Meeting Abstract
저널명
Annals of Oncology
33
페이지
S125 ~ S126